학술논문

Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 Study of MLN0128 (TAK-228) in Patients with Tumors with TSC1 or TSC2 Mutations: Sub-protocol EAY131-M
Document Type
Article
Source
In: European Journal of Cancer, 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. (European Journal of Cancer, October 2022, 174:S25)
Subject
Language
English
ISSN
18790852
09598049